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Oxidative stress-induced decrease in tissue or systemic glutathione (GSH) and damage to the vascular
endothelium of the blood-brain barrier such as occurs in diabetes or stroke will have important
implications for brain homeostasis. Endothelial proliferation or repair is crucial to preserving barrier
function. Cell proliferation has been associated with increased intracellular GSH, but the kinetic and
distribution of GSH during cell cycle is poorly understood. Here, we determined the inﬂuence of cellular
GSH status on the early dynamics of nuclear-to-cytosol (N-to-C) GSH distribution (6-h interval) during
proliferation in a human brain microvascular endothelial cell line (IHEC). Control IHECs exhibited two
peak S-phases of the cell cycle at 48 and 60 h post seeding that temporally corresponded to peak
nuclear GSH levels and expression of cdk1, the S-to-G2-to-M checkpoint controller, suggesting a link
between cell cycle progression and nuclear GSH. Sustained inhibition of GSH synthesis delayed S-to-G2/
M cell transition; cell arrest in the S-phase was correlated with decreased total nuclear GSH and
increased nuclear expressions of chk2/phospho-chk2 and GADPH. The temporal correspondence of
nuclear chk2 activation and GAPDH expression with S-phase prolongation is consistent with enhanced
DNA damage response and extended time for DNA repair. Strikingly, when GSH synthesis was restored,
cell transit time through S-phase remained delayed. Signiﬁcantly, total nuclear GSH remained
depressed, indicating a time lag between restored cellular GSH synthetic capacity and recovery of
the nuclear GSH status. Interestingly, despite a delay in cell cycle recovery, nuclear expressions of
chk2/phospho-chk2 and GAPDH resembled those of control cells. This means that restoration of nuclear
DNA integrity preceded normalization of the cell cycle. The current results provide important insights
into GSH control of endothelial proliferation with implications for cell repair or wound healing in
recovery post-oxidative damage.
& 2013 The Authors. Published by Elsevier B.V.Open access under CC BY-NC-ND license. Introduction
Recent ﬁndings support an intrinsic role for redox control of the
cell cycle. Progression through the cell cycle at deﬁned times is
inﬂuenced by the cellular redox environment, which modulates the
activity of cell cycle redox-sensitive proteins [1]. The redox environ-
ment within a cell is determined by the ratio of the concentration ofer B.V.
e disulﬁde; H1, histone H1;
iectasia mutated; chk2,
phate dehydrogenase
: þ1 318 675 7393.
Open access under CC BY-NC-Nthe reduced and oxidized forms of various redox couples, such as
glutathione (GSH), thioredoxin (Trx), and pyridine nucleotides [2,3].
Glutathione/glutathione disulﬁde (GSH/GSSG) is the most abundant
thiol redox buffer in cells and quantitatively plays a key role in the
maintenance of the cellular redox environment. GSH participates in
multiple metabolic functions and redox signaling, including thiol-
disulﬁde exchange and protein S-glutathiolation. Such redoxmechan-
isms modulate the function of redox-sensitive protein cysteines, such
as those involved in cell growth, proliferation, differentiation, or
apoptosis [4,5]. Thus, GSH is recognized as a regulator of cell
proliferation. GSH synthesis is a pivotal contributor to cytosolic GSH
homeostasis that impacts the redox states of intracellular compart-
ments of mitochondria, nucleus, and endoplasmic reticulum. Notably,
the nuclear-to-cytosol (N-to-C) distribution of GSH is reportedly a
factor in redox-based signaling in cell proliferation [6].
Vascular endothelial cells are located at the interface between
the vascular lumen and underlying tissues, and as such, are inD license. 
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such as diabetes, elevated levels of systemic or locally generated
mediators, free radicals, and reactive oxygen or carbonyl species
can contribute to the disruption of the vascular endothelium [7].
Therefore, the preservation or post-injury restoration of endothe-
lial barrier integrity is central to the maintenance of endothelial
function. A major mechanism for the repair and/or restitution of
the endothelial monolayer is proliferation of endothelial cells
adjacent to the lesion or injury site. Little is known of the
contribution of GSH to the control of vascular endothelial cell
proliferation.
The current study is designed to examine the inﬂuence of
cellular GSH status on the kinetics of N-to-C GSH distribution in a
human brain microvascular endothelial cell line, and the changes
in the expression of the cell cycle checkpoint controller, cdk1, and
DNA damage response markers, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), and phospho-chk2. Previous studies of
GSH and cell growth in epithelial [8] and 3T3 ﬁbroblasts [6] have
focused on 24 h time intervals or days, which, while convenient,
missed the crucial dynamic and shorter window of GSH-cell cycle
changes during cell proliferation. In this study, we have selected
6-h time intervals post-seeding throughout a 72 h culture. Our
results bring new insights into the early temporal changes
in endothelial N-to-C GSH distribution and the relationship to
S-phase responses in the cell cycle under conditions of normal,
decreased, or restored GSH states following initial GSH depletion.
Signiﬁcantly, our results provide novel evidence that inhibition of
endothelial GSH synthesis lengthened the resident time of
endothelial cells in the S-phase of the cell cycle that was
coincident with decreased nuclear GSH and activation of DNA
damage responses. These results suggest that decreased nuclear
GSH may be associated with enhanced DNA damage and that a
delay in S-to-G2-to M progression allows for extended time for
DNA repair and cell survival.Methods
Reagents
Medium 199, L-buthionine-(S,R)-sulfoximine (BSO), insulin-
transferin-sodium selenite solution, propidium iodine (PI), iodoa-
cetic acid (IAA), 2,4-dinitrophenyl ﬂuorobenzene (DNFB), ethanol,
trichloracetic acid (TCA), imidazol, sucrose, RNAase A were
purchased from Sigma-Aldrich (St. Louis, MO). Digitonin was
purchased from Wako, Japan. Protease and phosphatase inhibitor
cocktail (Complete Mini, EDTA and PhosphoStop, EDTA free,
1 tablet of each in 10 ml lysis buffer) were purchased from Roche
Diagnosis (Indianapolis, IN). Fetal bovine serum (FBS) was
obtained from Atlanta Biologicals (Lawrenceville, GA). Trypsin-
EDTA and antibiotic/antimycotic were from Gibco (Carlsbad, CA).
Puriﬁed mouse monoclonal anti-b actin and anti-cdk1 antibodies
were purchased from BD Biosciences (San Jose, CA). Mouse
monoclonal anti-GAPDH and anti- H1 antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA), and mouse monoclonal anti-
chk2 and rabbit monoclonal anti-phospho-chk2 antibodies were
from Millipore (Temecula, CA).
Cell culture
The human brain endothelial cell (IHEC) line was obtained
from Dr. Danica Stanimirovic at the National Research Council,
Canada Institute for Biological Sciences and was propagated by
Dr. Steven J. Alexander at LSUHSC—Shreveport, LA. IHECs were
maintained in 75 cm2 culture ﬂasks in M199 media supplemented
with 10% FBS, 1% insulin–transferrin–sodium selenite solution,and 1X antibiotic/antimycotic (complete M199 media) until
conﬂuence. Cells were incubated in humidiﬁed atmosphere with
5% CO2 at 37 1C. Media was changed every 2 days.
Cell incubations
For all experiments cells from conﬂuent IHEC monolayer were
seeded at a density of 2105/well in 6-well plates and cultured
for 0–72 h with a media change at 28 h post seeding. Cells were
collected at the following time points: 0 (at seeding), 30, 36, 42,
48, 55, 60, 66, and 72 h. To inhibit GSH synthesis, cells were
treated with 10 mM BSO at 4 and 24 h after seeding with a change
to fresh media at 28 h. Sustained decrease in cellular GSH was
maintained with the addition of 2 mM BSO in the fresh media. To
allow for re-synthesis of GSH, the 2 mM BSO dose was omitted
from the fresh media. At designated time points, cells were
harvested for ﬂow cytometric analyses of S-phase responses in
the cell cycle, for cellular fractionation and GSH determination, or
for Western blot analyses.
Cell cycle analysis by ﬂow cytometry
At each designated time point cells were trypsinized, washed
with PBS and ﬁxed in 70% cold ethanol. Fixed cells were
centrifuged at 4 1C, 1200 rpm for 10 min to remove ethanol,
resuspended in 1 mL PBS, and incubated with 1 mg/mL DNAse-
free RNAase A for 40 min at 37 1C. Propidium iodine (PI, 50 mg/ml)
was added and samples were incubated at 4 1C for 15 min in the
dark. Flow cytometric analysis was performed using a BD Bios-
ciences LSRII Flow Cytometer (San Jose, CA). A minimum of
2106 cells per sample was counted. Data was processed using
the Cell Quest software and gated on pulse-processed PI signals to
exclude doublets and large aggregates, using a multiparameter
gate strategy.
Cellular fractionation
Separation of cytosolic and nuclear fractions was achieved by
digitonin fractionation [9]. Cells were trypsinized, counted, and
fractionation was performed in 1.5 mL eppendorf tubes. Brieﬂy,
3106 cells were resuspended in 0.5 mL of fractionation buffer A,
containing 0.25 M sucrose, 3 mM imidazol, pH 7.4, and 1 mg/mL
digitonin. When samples were used for GSH measurements, cell
trypsinization and fractionation buffer A also contained 8 mM
iodoacetic acid. Cells were centrifuged at 14,000g (20 s, 4 1C) and
the supernatant was collected as the cytosolic fraction. The pellet
was resuspended in 0.5 mL fractionation buffer A, homogenized
with a Dounce homogenizer (5–10 passes) and centrifuged at
14,000g, 4 1C (3 s). The resultant pellet, representing the nuclear
pellet was washed twice in 0.5 mL buffer A (2 s at 14,000g, 4 1C).
The ﬁnal nuclear pellet was washed once with 0.5 mL PBS. For
GSH measurements, cytosolic and nuclear fractions were treated
with 5% ice-cold TCA prior to analyses. The purity of nuclear and
cytosolic fractions was validated by the enrichment of histone H1
on western blots and lactate dehydrogenase activity, respectively.
Quantiﬁcation of GSH
Cellular levels of GSH were determined by high-performance
liquid chromatography (HPLC) [10] as we previously described
[11,12]. TCA-soluble proteins were derivatized with 6 mM
IAA and 1% 2, 4 DNFB to yield the S-carboxymethyl and 2,
4-dinitrophenyl derivative of GSH, respectively. Separation of GSH
derivatives was performed on a 2504.6 mm Alltech Lichrosorb
NH2 10 mm anion-exchange column. GSH contents were quantiﬁed
by comparison to standards derivatized in the same manner. Protein
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tion. GSH concentrations were expressed as nmoles/mg protein.
Western blot analyses
Protein expressions of cyclin-dependent kinase, cdk-1, histone
H1, DNA damage response genes (GAPDH, cell cycle checkpoint
regulator, chk-2 and phospho-chk2), and b-actin were deter-
mined by western blot analyses. At designated times, cells were
suspended in a reducing buffer containing 0.5 M Tris, 10% SDS,
glycerol, b-mercaptoethanol, phenol red and a protease and
phosphatase inhibitor cocktail, and then sonicated. 30 mg proteins
of cytosolic or nuclear extracts were loaded onto 10% or 4–10%
polyacrylamide gels and size separated at 110–115 V. Proteins
were transferred onto PVDF membranes overnight at 30 V, 4 1C.
Membranes were blocked in 5% milk or BSA in TBS-Tween at
room temperature for 1 h and then incubated with the respective
antibodies as follows: anti-histone H1 (1:3000), anti-chk2
(0.150 mg/mL), anti-p-chk2 (1:2000), anti-cdk1 (1:10,000), anti-b
actin (1:75,000), and anti-GAPDH (1:1000). After washing, mem-
branes were incubated in HRP-conjugated goat-anti-mouse or
anti rabbit secondary antibody for 1 or 2 h at room temperature
followed by washing and 5 min incubation with ECL reagents per
the manufacturer’s protocol. Detection was performed using
radiographic ﬁlms. Quantiﬁcation of band intensity relative to
b-actin or H1 was performed for at least 4 separate blots from 2 to
3 experiments performed in duplicates. Results are mean7SEM.
Equal protein loading was assessed by Ponceau red stainingFig. 1. Temporal relationship between cell cycle S phase and nuclear-to-cytosolic (N-to
2105/well in 6 well plates for 72 h. Media was changed at 28 h (arrow) and cell samp
analysis and cell fractionation and GSH measurements. Details on achievement of sus
(A) shows the percent of cells in the S-phase of the cell cycle for control, GSH-depleted (
analyses for effects of Group, times and group-time interactions are summarized in Ta
nucleus (open circle) for controls, treated or reversal. Results are mean7SEM and stati
are summarized in Table 2. (C) illustrates the relationship between % of cell in the S-pha
of GSH and % cells in S-phase, respectively at times 36, 42, 48, 55, 60 and 66 h.which showed uniform staining in all western blots. b-actin
expression was relatively uniform at the different times, but the
expression levels of H1 on western blots (Figs. 2–4) were notably
variable, suggesting that the purity of the nuclear fraction from
one cell preparation to another can be quite varied, a recognized
limitation of the fractionation procedure. However, the relative
expressions of nuclear cdk1, chk2 or GAPDH paralleled the
respective changes in H1 levels; therefore, quantiﬁcation of their
band intensities were performed relative to H1.
Protein assay
Protein contents were measured using the Bio-Rad Protein
Assay kit (Bio-Rad Laboratories, Hercules, CA), according to
manufacturers’ protocol.
Statistical analysis
Two-Factor Analysis of Variance (ANOVA) was used to deter-
mine signiﬁcant effects of group namely, Control cells, GSH
depleted cells (Treated) and GSH restored cells (Reversal), times
(30, 36, 42, 48, 55, 60, 66 and 72 h), and interaction between
group and time. For each of the three variables, multiple (pair
wise) comparisons among the 3 groups and among the 8 time
points were performed using the Bonferoni method. Results are
expressed as mean7SEM. The relationships between % cell in
S-phase and nuclear GSH were analyzed by linear regression
analysis. The slope of the ﬁtted line is signiﬁcant for control.-C) GSH distribution. Cells were cultured in complete M199 media at a density of
les were harvested at every 6-h interval starting at 30 h post seeding for cell cycle
tained GSH depletion and GSH recovery were described in the Methods section.
Treated), and GSH-restored (Reversal) cells. Results are mean7SEM and statistical
ble 1. (B) shows the concentrations of GSH in the cytosol (ﬁlled squares) or in the
stical analyses for effects of Group and Group means for cytosolic and nuclear GSH
se and nuclear GSH levels. Horizontal and vertical error bars represent mean7SEM
Fig. 2. Time course of protein expression of cdk1, a cell cycle checkpoint controller of S-to-G2-to-M progression. (A) Western blot analyses of cdk1 expression from
0–to–72 h in the cytosolic or nuclear fractions prepared from control IHECs (Control), cells treated with BSO to maintain low GSH (Treated) or cells treated with BSO that was
subsequently removed to allow for GSH recovery (Reversal). (B) shows the quantitative data of band intensities of cytosolic (closed circles) or nuclear (open circles) cdk1
expression relative to b-actin or H1, respectively for the 3 treatment groups. Results are mean7SEM for 4 separate blots. C illustrates the N-to-C ratios of cdk1. Statistical
differences for time-group interactions among the 3 groups in (B and C) are denoted by letters a, b, c that are explained in the statistical analyses on the ﬁgure.
Fig. 3. Kinetics of expression of nuclear chk2 and its phosphorylation status. (A) Western blot analyses of nuclear expression of chk2 and phospho-chk2 from 0–to–72 h in
nuclear fractions prepared from control IHECs, cells treated with BSO to maintain low GSH (Treated) or cells treated with BSO that was subsequently removed to allow for
GSH recovery (Reversal). (B) shows the quantitative data of band intensities of nuclear chk2 (closed circles) or phospho-chk2 (open circles) expression relative to H1 for the
3 treatment groups. Results are mean7SEM for 4 separate blots. (C) illustrates the N-to-C ratios of p-chk2-to-chk2. Statistical differences for time-group interactions
among the 3 groups in (B and C) are denoted by letters a, c that are explained in the statistical analyses on the ﬁgure.
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Fig. 4. Time course of cytosolic and nuclear expression of GAPDH, an index of DNA damage response. (A) Western blot analyses of expression of GAPDH from 0 to 72 h in
cytosolic and nuclear fractions prepared from control IHECs, cells treated with BSO to maintain low GSH (Treated) or cells treated with BSO that was subsequently removed
to allow for GSH recovery (Reversal). (B) shows the quantitative data of band intensities of cytosolic GAPDH (closed circles) or nuclear GAPDH (open circles) expression
relative to b-actin or H1, respectively, for the 3 treatment groups. Results are meanþSEM for 4 separate blots. (C) illustrates the N-to-C ratios of nuclear-to-cytosolic
GAPDH. Statistical differences for time-group interactions among the 3 groups in (B and C) are denoted by letters a, b, c that are explained in the statistical analyses on the
ﬁgure.
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Cellular GSH manipulation on cell cycle responses and cytosolic and
nuclear GSH contents
The relationship between IHEC proliferation and GSH was
examined by cell cycle analyses (Fig. 1, Table 1). Regardless of
treatment conditions, media change elicited rapid entry of IHECs
into cell cycle with a peak S-phase at 30 h. However, signiﬁcant
differences in cell cycle response among groups were observed
between 36 and 66 h. Over this time period, % cells in S-phase
exhibited two distinct peaks at 48 h and 60 h (peak S-phases,
Fig. 1A). Speciﬁcally, peak S-phases at these times were signiﬁ-
cantly higher than at 42, 55, 66, and 72 h (Table 1B), indicating
that under normal conditions, control cells underwent two
rounds of cell cycle. In contrast, GSH-depleted (Treated) cells
exhibited a single S-phase peak between 36 h and 66 h (Fig. 1A),
consistent with a dramatic increase in the resident time of cells in
the S-phase in conjunction with cellular GSH depletion. Remark-
ably, the S-phase proﬁle in the reversal state was identical to that
of GSH-depleted cells, indicating that cell transition from S-to-G2
remained delayed.
Cytosolic and nuclear GSH contents were examined in parallel
with cell cycle changes. In control cells, cytosolic GSH time-
dependently decreased from 30 to 60 h, while nuclear GSH was
cyclical, exhibiting two peaks between 42 and 48 h and at 60 h
(Fig. 1B) that temporally correlated with the two peak S-phases
(Fig. 1A). Signiﬁcantly, there was a positive correlation of % cells
in S-phase with nuclear GSH (R¼0.67, Fig. 1C). BSO treatment
decreased cytosolic GSH that was o50% lower than controls(Table 2). Nuclear GSH contents were similarly decreased post
BSO-treatment; interestingly, a cyclical pattern of nuclear GSH
remained evident even though the levels at various times were
not statistically different (Fig. 1B). Importantly, there was no
positive linear correlation of % cells in S-phase with nuclear GSH
under these GSH-depleted conditions (Fig. 1C). During reversal,
the contents of cytosolic GSH, nuclear GSH and its cyclical
pattern, as well as the relationship between % cells in S-phase
with nuclear GSH resembled those of GSH-depleted cells (Fig. 1,
Table 2).
GSH status and cytosolic and nuclear expression of cdk1
The expression kinetics of the cell cycle checkpoint controller,
cdk1, was determined to further investigate the relationship of
cell cycle and GSH. The results revealed distinct patterns of cdk1
expression in the cytosolic and nuclear fractions among the
treatment groups. In control cells, cytosolic cdk1 was elevated
between 36 h and 60 h while nuclear cdk1 exhibited peaks and
troughs, statistically higher values occurring at 48 and 66 h
(Fig. 2A, B). These peak nuclear cdk1 responses temporally
correlated with that of peak S-phase responses (within 6 h, see
Fig. 1A), consistent with the function of cdk1 in S-to-G2-to-M
transition [13]. Over this time period, GSH-depleted cells elicited
high expression of cytosolic cdk1, but uniformly low expression of
nuclear cdk1 (Fig. 2B). During reversal, nuclear cdk1 expression
remained depressed even though cytosolic cdk1 returned to near
control levels (Fig. 2B). Of note, the nuclear-to-cytosolic cdk1
ratios in GSH-depleted and GSH-restored cells were signiﬁcantly
lower (as a group) when compared to control cells, in accordance
Table 1
A Effects of Group, Time and Group-Time Interaction and Group Means for S-Phase among control cells, GSH-
depleted (Treated) cells and GSH-restored (Reversal) cells.
Effect N a Mean7SD b p-value
Group o0.01nn
Control 36 35.8710.6 c
Treated 48 44.4714.7
Reversal 36 43.9714.7
Time point o0.01nn
42 h 20 33.173.6
48 h 20 49.376.3 d
55 h 20 53.9717.9 d
60 h 20 52.777.5 d
66 h 20 32.272.3
72 hour 20 28.675.1
Group–time interaction o0.01nn
42 h—Control 6 30.374.6
Treated 8 33.473.1
Reversal 6 34.971.7
48 h—Control 6 44.579.4
Treated 8 52.871.5
Reversal 6 50.373.3
55 h—Control 6 27.774.3 e
Treated 8 66.774.4
Reversal 6 63.971.5
60 h—Control 6 51.675.4
Treated 8 52.479.4
Reversal 6 53.878.1
66 h—Control 6 33.473.4
Treated 8 30.772.0
Reversal 6 32.570.6
72 h—Control 6 27.474.7
Treated 8 30.574.8
Reversal 6 28.175.9
B Comparisons among six time points for control cells.
Time point N Mean7SD p-value
42 h 6 30.374.6 o0.1nn
48 h 6 44.579.4 f
55 h 6 27.774.3
60 h 6 51.675.4 f
66 h 6 33.473.4
72 h 6 27.474.7
a N—number of observations.
b SD—Standard deviation.
c Control signiﬁcantly lower than the other 2 groups.
d Signiﬁcantly higher than 42 h, 66 h, &and 72 h.
e Control signiﬁcantly lower than the other 2 groups.
f Signiﬁcantly higher than 42 h, 55 h, 66 h and 72 h; troughs at 42 h, 55 h, 66 h, and 72 h; peaks at 48 h and 60 h.
nn Signiﬁcant at 1% level (p-valueo0.01).
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reﬂected in a prolongation of the S-phase (see Fig. 1A).
GSH status on chk2 activation status and GAPDH expression
A signiﬁcant decrease in nuclear GSH in BSO-treated cells
suggested the possibility of enhanced DNA damage which would
elicit a DNA damage response. To address this, we determine the
nuclear activation of chk2 and the nuclear-to-cytosol distribution
of GAPDH, indices of DNA damage response and repair, respec-
tively. Chk2 is a downstream effector of the ataxia telangiectasia
mutated (ATM) signaling pathway that is often associated with
the DNA damage signaling network [14], while GAPDH is a
pleiotropic enzyme known to function in mRNA stability, DNA
repair and cell cycle progression [15–18]. In control cells, nuclear
chk2 was notably low between 0 h and 42 h and at 55 h; elevated
nuclear chk2 was evident at 48 h and was strongly expressed
between 60 h and 72 h (Fig. 3A, B). The phosphorylation of
nuclear chk2 was strong at all times (Fig. 3). In BSO-treated cells,the expression proﬁle of nuclear chk2 resembled that of controls
but quantitatively lower; however, as a group the proportion of
phospho-chk2-to-chk2 was signiﬁcantly higher especially at
times between 30 h and 42 h and at 55 h (Fig. 3C), consistent
with early increase in chk2 phosphorylation in conjunction with
GSH depletion. It is notable that this increase in chk2 activation
occurred over a 6 h time period prior to cell entry into the
prolonged S-phase. During reversal, nuclear chk2 expression and
phospho-chk2-to-chk2 ratios resembled those in control cells that
was statistically lower than BSO-depleted cells (Fig. 3), suggesting
that GSH recovery was associated with chk2 de-phosphorylation.
Cytosolic GAPDH expressions were not different among groups
and were characteristically higher at 30 and 60 h post-seeding
(Fig. 4A, B). However, statistical differences were observed in
group and time-group effects among control and treatment
groups in that GSH synthesis inhibition elicited higher nuclear
GAPDH expression and N-to-C ratios than control conditions and
during reversal. Signiﬁcantly higher nuclear GAPDH levels in
GSH-depleted cells were evident at all time points except at
Table 2
Effect of group and group means for cytosolic and nuclear GSH among control cells, GSH-depleted (treated) cells and GSH-restored (reversal) cells.
Effect Na Mean7SD b p-value Effect Na Mean7SD b p-value
Cytosolic GSH Nuclear GSH
Group o0.01nn Group o0.01nn
Control 54 1.6971.18 c Control 54 0.0770.03 c
Treated 54 0.4370.33 Treated 54 0.03770.01
Reversal 54 0.6470.28 Reversal 54 0.04270.02
a N—number of observations.
b SD—Standard deviation.
c Control signiﬁcantly higher than the other 2 groups.
nn Signiﬁcant at 1% level (p-valueo0.01).
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linked to DNA damage responses, which could contribute to a
delay in cell transition from S-to-G2 to favor DNA repair.Discussion
The dynamic relationship between nuclear and cytosolic GSH
compartmentation and cell cycle responses at the early time
points (6 h intervals) during proliferation of endothelial cells is
poorly understood. Our current study shows for the ﬁrst time that
brain microvascular endothelial cells (IHECs) exhibit distinct cell
cycle characteristics post-seeding after an initial 30-h quiescent
period, depending on the cellular GSH status. Under normal
conditions, control IHECs completed two cycles of cell division
with peak S-phases at 48 h and 60 h (Fig. 1A) which temporally
associate with peak nuclear expressions of cdk1 and nuclear GSH
at these times. These results suggest a link between cell cycle
progression and nuclear GSH [19], a suggestion that was sup-
ported by the ﬁnding of a positive correlation between % cells in
S-phase of cell cycle with nuclear GSH levels. The cyclical pattern
of nuclear GSH over the 12-h period is an interesting observation
that could reﬂect an impact of circadian rhythm that is separate
from cell cycle. However, the relationship between biological
rhythms and cell cycle is not easily resolved in cell culture studies
given our lack of understanding of the regulation of biological
clocks in vitro. Indeed, most of the studies on circadian biology are
conducted in animal studies wherein clock genes were mutated
to determine their impact on GSH rhythms [20,21].
A novel observation in our study is that decreased nuclear
GSH is associated with a delay in cell exit from S-phase in the
cell cycle. Strikingly, only one peak S-phase was evident in
BSO-treated cells as compared to control cells that typically
proceeded with two rounds of cell cycle over the same time
period (Fig. 1A). This slowed S-to-G2 progression in GSH-depleted
cells was preceded by higher localization of the checkpoint
controller, cdk1 in the cytosol (Fig. 2), suggesting that cytosol-
to-nuclear cdk1 translocation was decreased by a disruption in
the GSH status [22,23]. Importantly, under GSH disruption, a
positive linear correlation of % cell in S-phase with nuclear GSH
was no longer evident; rather it appears that the arrest of cells in
the S-phase corresponded to a signiﬁcant decrease in the total
nuclear GSH content (Table 2). It is notable that a 450% decrease
in baseline cytosolic GSH was reﬂected in 50% decrease in nuclear
GSH; however the nuclear GSH pool appeared to retain an
inherent cyclical proﬁle and was relatively stable over 72 h [24].
This means that the GSH status within the cytosolic and nuclear
compartments is differentially controlled during cell cycle in
favor of nuclear GSH accumulation. The results are also consistent
with a slower turnover of the nuclear GSH pool which would
ensure the preservation of critical cysteine residues of nuclear
proteins, such as histones, telomerase, and polyADP ribose [25],and the maintenance of a reducing nuclear environment that
promotes DNA binding and gene expression [26].
The correspondence of decreased nuclear GSH with a pro-
longed S-phase in BSO-treated cells is consistent with the follow-
ing scenario during active DNA synthesis: increased oxidative
DNA damage at low nuclear GSH would result in a DNA damage
response and induce S-phase arrest, thus providing an extended
time for DNA repair. Our current results support the suggestion
that inhibition of GSH synthesis elicited DNA damage response
and repair as evidenced by elevated nuclear chk2 phosphorylation
(activation) and increased N-to-C GAPDH distribution, prior to
peak cell arrest in S-phase. Enhanced cytosol-to-nuclear GAPDH
translocation [27] is evidenced by an increase in nuclear GAPDH
in conjunction with decreased cytosolic GAPDH.
Recent studies demonstrated that GAPDH is a substrate for the
ATM/ATR pathway [28], implicating a role for nuclear chk2. The
presence of phosphorylated chk2 in the nucleus of quiescent cells
means that DNA replication is not an error free process under
physiological conditions, and that a basal activity for DNA repair
exists to maintain the integrity of nuclear DNA. Moreover, chk2-
mediated phosphorylation was shown to be essential in accurate
spindle assembly in normal mitosis [29,30]. However, the extent
of chk2 phosphorylation relative to chk2 is lower in quiescent and
proliferating control cells and increased markedly during GSH
deﬁciency. An enhanced nuclear phospho-chk2-to-chk2 ratio
between 30 h and 55 h in GSH-compromised cells is consistent
with activation of the chk2/ATM/ATR pathway for DNA repair,
likely in response to elevated DNA damage secondary to
decreased nuclear GSH. Since phospho-chk2 is an inhibitor of
Cdc 25C that is required for cyclin B-cdk1 complex activation and
G2M transition [31], the delay in S-to-G2 transition (Fig. 1A) and
greater retention of cdk1 in the cytosol of GSH-depleted cells
(Fig. 2A) would correlate with an increase in chk2 activation in
these cells.
It is remarkable that the reversal of GSH inhibition and
restored GSH synthetic capacity did not restore endothelial cell
cycle vis-a-vis S-to-G2 progression over 72 h post BSO removal. A
possible explanation is the temporal delay in recovery of nuclear
GSH which remained depressed over this time frame (Fig. 1B).
Low nuclear GSH was reﬂective of decreased cytosolic GSH
(Table 2); presumably, during reversal and active proliferation,
amino acids (including cysteine, glutamate, glycine) were prefer-
entially utilized for protein synthesis rather than GSH synthesis.
However, despite a delay in cell cycle recovery, there was
evidence that IHECs were transitioning to the control phenotype,
as evidenced by the expressions of nuclear chk2 and GAPDH
which resembled control cells. The attenuated DNA damage
responses would be consistent with restored nuclear DNA integ-
rity such that cells can begin to exit the S-phase and proceed with
normal cell cycle. A lagging time line for normalization of S-phase
progression behind that of decreased DNA damage responses is
consistent with this interpretation.
Fig. 5. Endothelial cell cycle responses under physiological and GSH-deﬁcient states. During cell proliferation, cytosol-to-nuclear GSH transport is increased under
physiological GSH conditions. An increase in intra-nuclear reducing environment promotes gene transcription that brings about normal cell cycle progression wherein
DNA synthesis occurs during the S-phase. Normal nuclear cdk1expression controls S-to-G2-to-M cell transition. Decreased cytosolic GSH due to inhibition of synthesis or
enhanced oxidative stress results in decreased nuclear GSH import. Low nuclear GSH induces a DNA damage response, presumably due to increased oxidative DNA
damage. An increase in chk-2 activation (increased p-chk2) and nuclear GAPDH accumulation contributes to a prolongation of the S-phase and a delay in cell cycle
progression. In part, increased p-chk2 promotes the retention of cdk1 in the cytosol; a decrease in nuclear cdk1 delays the S-to-G2-to-M transition. Signiﬁcantly, the
lengthening of the S-phase allows for extended time for DNA repair.
C. Bus´u et al. / Redox Biology 1 (2013) 131–139138To our knowledge, the current ﬁndings are the ﬁrst to establish
a temporal link between nuclear GSH, DNA damage response, and
the S-phase of the cell cycle in brain microvascular endothelial
cells in the normal and GSH-deﬁcient states (Fig. 5). These
ﬁndings complement and extend recent studies of GSH changes
and epithelial cell proliferation [32]. Importantly, our results
provide insights into the relationship between cellular GSH
disruption and recovery and cell cycle progression at 6-h intervals
during endothelial proliferation in the ﬁrst three days post
emergence from quiescence. This approach allowed us to better
describe the inﬂuence of nuclear GSH changes on up-or-down
expressions of cdk1, GAPDH, chk2 and its activation state
between the times of 36h and 60 h during active cell proliferation.
At present, the mechanistic relationships that govern nuclear
GSH, proliferation-associated responses in the cell cycle, DNA
damage response, and activation of DNA repair are unknown and
are the subjects of current investigation in the laboratory.
In the current study, the IHEC cell line was used as a surrogate
of the blood-brain barrier endothelium in vivo. The capability of
the cerebral microvascular endothelial monolayer to repair itself
after wounding is critical to preserving blood-brain barrier func-
tion against ﬂuctuating systemic inﬂuences to maintain brain
homeostasis [7]. Furthermore, an understanding of the intrinsic
role for GSH control of endothelial proliferation and restitution
will have key implications for endothelial integrity in various
microvascular beds under conditions of oxidative stress or asso-
ciated vascular pathologies. Future therapeutic approaches that
target endothelial restoration post oxidative insult would have
signiﬁcant clinical implications for the neurovascular disorders of
diabetes and stroke and more broadly, for other neurodegenera-
tive and neurological disorders as well.Acknowledgment
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